GLP-1s, Peptides & Longevity
What semaglutide, tirzepatide, and the newer peptides actually do, what the trials show, and where the longevity evidence stands.
FASDP · FCAP · FASCP
Amin
Hedayat, MD
Dermatopathologist and Metabolic Health Physician
Metabolic & Obesity Medicine
Metabolic & Obesity Medicine
UNINFLAMED™
I turn complex medical science into clear, practical answers, so you understand your body and make choices with confidence.
Board-Certified
Dermatopathology,
Anatomic & Clinical Pathology
Fellowship
Memorial Sloan Kettering,
Weill Cornell & UC San Francisco
Residency
Dartmouth
Who I Am
A pathologist
who explains medicine.
I'm triple board-certified in dermatopathology, anatomic pathology, and clinical pathology. I serve as a Medical School Assistant Clinical Professor and practice medicine full time.
I completed my dermatopathology fellowship at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, where I trained under internationally renowned dermatopathologists and dermatologists. I completed my residency at Dartmouth.
I've authored numerous peer-reviewed publications and book chapters on advanced molecular testing in melanoma, melanocytic tumors, and cutaneous lymphoma. I've presented at national and international scientific meetings, and I'm committed to fighting skin cancer through clinical practice, education, and research.
I completed my obesity medicine education in line with the requirements of the American Board of Obesity Medicine.
My clinical focus is metabolic health and longevity: how insulin resistance and chronic inflammation shape how long, and how well, people live. I've also trained in facial aesthetics.
What we call normal is the average of a sick population. That bar is too low.
I teach longevity tools you can check against the evidence and use the same day, in changes small enough to keep.
1% better than yesterday.
Connect
Follow the work.
New lectures, podcast episodes, and research updates, wherever you prefer to learn.
YouTube
@DrAminHedayatLong-form lectures on metabolic health and new therapies.
Podcast on Spotify
Dr. Amin Hedayat, MDEvery episode as audio or video, on your schedule.
Instagram
@draminhedayatShort clips and highlights from each episode.
LinkedIn
Amin Hedayat, MDProfessional background, appointments, and research.
Education Platform
UNINFLAMED™Guided programs and a members community for metabolic health, including The GLP-1 Method.
Visit getuninflamed.comNonprofit Leadership
American Melanoma InstituteFounder and Chairman of the Board. A 501(c)(3) nonprofit dedicated to melanoma and skin cancer education.
Visit melanoma.instituteFocus Areas
Where I spend my attention.
Obesity Medicine
Obesity is a disease, not a willpower problem. Hormones, genetics, and metabolism set body weight, and they fight hard to defend it. I treat it like any chronic condition: medication when the evidence supports it, nutrition that fits real life, and follow-up that lasts.
Dermatopathology
A biopsy lands on my desk, and the tissue tells a story. My job is to read it. Under the microscope, I look at skin one cell at a time and name what is wrong. I catch melanoma hiding among ordinary moles, along with basal and squamous cell carcinoma. I sort out lymphomas that start in the skin, the rashes of lupus and psoriasis, infections, and blistering diseases. One slide can separate a harmless mole from a melanoma that needs treatment now.
Melanoma & Skin Cancer
Chairman of the board of the American Melanoma Institute, with published work on molecular testing in melanoma and cutaneous lymphoma.
Education Platform
UNINFLAMED™
Guided programs and a members community for metabolic health, including The GLP-1 Method.
Protected by reCAPTCHA. Google Privacy & Terms apply.
Visit getuninflamed.comOn YouTube
Watch on YouTube
Evidence, explained.
I break down the GLP-1 medications, the emerging therapies, and the metabolic science underneath them.
Latest Uploads
PublicationsPeer-reviewed
